HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ICCVAM Successes, Challenges Addressed At Anniversary Symposium

This article was originally published in The Rose Sheet

Executive Summary

Regulatory acceptance of validated animal alternative tests is the biggest challenge to the work of the Interagency Coordinating Committee on the Validation of Alternative Methods, according to the Personal Care Products Council

You may also be interested in...



Major U.S. Cosmetic Firms Say They Are Ready For Animal Test Ban In EU

The EU's upcoming ban on products tested on animals could affect the availability of some novel cosmetic ingredients, though it is unlikely to have a jarring impact on large U.S. personal-care marketers

Major U.S. Cosmetic Firms Say They Are Ready For Animal Test Ban In EU

The EU's upcoming ban on products tested on animals could affect the availability of some novel cosmetic ingredients, though it is unlikely to have a jarring impact on large U.S. personal-care marketers

ICCVAM Recommends Two Animal-Reducing Ocular Irritation Test Methods

Two in vitro ocular toxicity test methods for identifying severe irritants have been presented to federal agencies for approval as methods to reduce the number of animals used in testing, the National Toxicology Program's Interagency Coordinating Committee on the Validation of Alternative Methods reports

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015233

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel